SALIVARY GLAND CANCER
Clinical trials for SALIVARY GLAND CANCER explained in plain language.
Never miss a new study
Get alerted when new SALIVARY GLAND CANCER trials appear
Sign up with your email to follow new studies for SALIVARY GLAND CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New drug shows promise for rare salivary gland cancer
Disease control OngoingThis study tests a new drug called APG-115, alone or with chemotherapy, in people with a specific type of salivary gland cancer that has a normal p53 gene. The goal is to see if the drug can shrink tumors and to find the best dose with acceptable side effects. About 41 adults wit…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New combo aims to shrink stubborn thyroid and salivary tumors
Disease control OngoingThis study tests a combination of two drugs—pembrolizumab (an immunotherapy) and docetaxel (chemotherapy)—in people with advanced thyroid or salivary gland cancers that are not responding to standard treatments. The goal is to see if the combo can shrink tumors and help patients …
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for rare cancer: drug targets hard-to-treat tumors
Disease control OngoingThis study tests a drug called amivantamab in people with a rare salivary gland cancer (adenoid cystic carcinoma) that has spread or come back. The goal is to see if the drug can shrink tumors or slow the cancer's growth. About 21 adults with measurable disease and recent progres…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug combo shows promise for rare salivary gland cancers
Disease control OngoingThis study tests whether two drugs, lenvatinib and pembrolizumab, can shrink or slow the growth of advanced adenoid cystic carcinoma and other salivary gland cancers that have come back or spread. About 64 adults with these rare cancers will receive the drug combination. Research…
Matched conditions: SALIVARY GLAND CANCER
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC